Adjuvant chemotherapy for malignant fibrous histiocytoma in the femur and tibia

J Bone Joint Surg Am. 1985 Apr;67(4):620-5.

Abstract

Between 1974 and 1982, twelve patients with malignant fibrous histiocytoma of the femur and tibia were treated by excision and adjuvant chemotherapy. During the same time-period, eighteen patients were treated by excision alone. The disease-free survival rate among the former was 59 per cent (seven of twelve). There was only one survival in the latter group.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / surgery
  • Combined Modality Therapy
  • Female
  • Femoral Neoplasms / drug therapy
  • Femoral Neoplasms / surgery
  • Follow-Up Studies
  • Histiocytoma, Benign Fibrous / drug therapy*
  • Histiocytoma, Benign Fibrous / surgery
  • Humans
  • Male
  • Middle Aged
  • Tibia*